Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by retiredcopon Feb 09, 2022 8:11pm
153 Views
Post# 34414884

RE:RE:RE:RE:RE:RE:RE:RE:Michael Gordon of Fenway still part of PMN?

RE:RE:RE:RE:RE:RE:RE:RE:Michael Gordon of Fenway still part of PMN?This exit matter by certain investors came to the attention of the company through a network of investors who immediately felt it was wrong info and passed it onto the appropriate people who confirmed it was bad info and that followup would be done asap  .   
PMN has hired companies/ individuals in the past  that are responsible for social media like facebook and Twitter so no reason why they aren't on these types of boards. I known that a lot of the large investors prefer Twitter and stay off these types of boards. And what may come as a shock to some of you is that a lot of good information  is obtained with one to one messaging which is available on this site or once I trust a person they get my email or even phone number for text messages ...so some of you might want to try And get on this persons Good side and start communicating through the one on one message option... 
<< Previous
Bullboard Posts
Next >>